Menopause is a major neuroendocrine transition experienced differently by each person who goes through it. For many autistic women, this transition occurs in the context of pre-existing sensory sensitivities, cognitive demands, and cumulative stress, yet it remains under‑recognised and inconsistently addressed in healthcare settings. This blog outlines what menopause is, what changes are expected, and why it warrants careful clinical attention, particularly for autistic women and those who support them.
Menopause is not a single event or a sudden switch. It is a multi‑year transition with three broad phases:
The timing of menopause varies widely. Some women enter perimenopause in their late 30s or early 40s, while others do so later. Symptom profiles also vary substantially. Some women experience mild or transient changes, while others experience symptoms that significantly affect daily functioning. This variability is expected, but it can make menopause harder to recognise, especially when symptoms overlap with other health or neurodevelopmental factors.
Across the menopausal transition, women may notice changes in several domains. These changes are not universal, but they are common enough to be clinically meaningful:
For some women, these symptoms are mild. For others, they can disrupt work, routines, relationships, and overall wellbeing. Importantly, symptom burden, rather than symptom presence alone, often determines whether clinical attention is needed.
Menopause is a neuroendocrine transition characterised by fluctuating and declining ovarian hormone levels. These hormonal changes can influence multiple body systems, which is why menopause may affect sleep, temperature regulation, concentration, memory, and emotional regulation.
For many women, these changes are not limited to hot flushes. They can involve a broader shift in day‑to‑day capacity, resilience, and wellbeing. These effects vary widely between women and can change across stages of perimenopause and postmenopause.
In autistic women, these same changes may carry additional functional impact when they occur alongside sensory sensitivities, cognitive load, routine disruption, or chronic stress. This does not necessarily mean that menopause is biologically different in autistic women, but it may mean that the overall burden is greater, the effects are harder to manage, or the pattern is more difficult to interpret.
Menopause does not occur in isolation. It interacts with each woman’s sensory profile, routines, communication preferences, stress load, and support context. For autistic women, this interaction can increase the likelihood that symptoms are missed, misattributed, or minimised.
Changes in sleep, sensory tolerance, emotional regulation, or cognitive efficiency may be attributed to autism, anxiety, stress, or burnout rather than recognised as part of a menopausal transition. Communication differences, masking, or difficulty perceiving and describing internal bodily changes can further reduce the likelihood that symptoms are identified and addressed. Over time, this may delay assessment and support. It may also increase cumulative strain, particularly when outward expectations remain unchanged despite reduced capacity.
Recognising menopause as a clinically significant, multi‑system transition is important, particularly for autistic women. Attention to new or changing patterns in sleep, mood, cognition, sensory tolerance, and daily functioning may help clinicians, supporters, and autistic women themselves consider whether menopause could be contributing to any changes.
Our on-demand presentation, Menopause and Autism, explores these changes in greater depth, including how menopause may present in autistic women, why it can be missed, and how autistic women, clinicians, and supporters can better identify appropriate pathways for understanding and support.
Benevides, T., et al. (2024). Brief Report: Under‑Identification of Symptomatic Menopause in Publicly‑Insured Autistic People. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-024-06516-x
Brady, M. J., Jenkins, C. A., Gamble‑Turner, J. M., Moseley, R. L., Janse van Rensburg, M. G., & Matthews, R. J. (2024). “A perfect storm”: Autistic experiences of menopause and midlife. Autism. https://doi.org/10.1177/13623613241244548
Charlton, R. A., Happé, F., Shand, A. J., Mandy, W., & Stewart, G. R. (2024). Self‑reported psychological, somatic and vasomotor symptoms at different stages of the menopause for autistic and non‑autistic people. Preprint. https://doi.org/10.31219/osf.io/pqx85
Grant, A., et al. (2024). Participatory longitudinal qualitative interview study to understand autistic gynaecological and obstetric health: The Autism from menstruation to menopause study protocol. BMJ Open. https://doi.org/10.1136/bmjopen-2024-088343
Groenman, A. P., Torenvliet, C., Radhoe, T. A., Agelink van Rentergem, J. A., & Geurts, H. M. (2022). Menstruation and menopause in autistic adults: Periods of importance? Autism. https://doi.org/10.1177/13623613211059721
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: Addressing the unfinished agenda of staging reproductive aging. Menopause, 19(4), 387–395.
Hernandez, G. D., & Brinton, R. D. (2019). The neurological and immunological transitions of the perimenopause: Implications for postmenopausal neurodegenerative disease. In Estrogen Signaling: Implications for Parkinson’s Disease and Other Neurodegenerative Diseases. Springer. https://doi.org/10.1007/978-3-030-11355-1_2
Hull, L., Petrides, K. V., Allison, C., Smith, P., Baron‑Cohen, S., Lai, M.‑C., & Mandy, W. (2017). “Putting on my best normal”: Social camouflaging in adults with autism spectrum conditions. Journal of Autism and Developmental Disorders, 47(8), 2519–2534.
Hwang, W. J., Lee, T. Y., Kim, N. S., & Kwon, J. S. (2020). The role of estrogen receptors and their signaling across psychiatric disorders. International Journal of Molecular Sciences, 22(1). https://doi.org/10.3390/ijms22010373
Jenkins, C., Moseley, R., Matthews, R., Janse van Rensburg, M., Turner‑Cobb, J. M., & Brady, M. J. (2024). “Struggling for years”: An international survey on autistic experiences of menopause. Neurodiversity. https://doi.org/10.1177/27546330241299366
Karavidas, M., & de Visser, R. O. (2021). “It’s not just in my head, and it’s not just irrelevant”: Autistic negotiations of menopausal transitions. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-021-05010-y
Moseley, R. L., Druce, T., & Turner‑Cobb, J. M. (2020). “When my autism broke”: A qualitative study spotlighting autistic voices on menopause. Autism, 24(6), 1423–1437. https://doi.org/10.1177/1362361319901184
Piper, H., & Hutson, J. (2024). Neurovascular shifts, sensory sensitivity, and PMDD in autistic women: Exploring blood flow redirection, mood dysregulation, and pain tolerance during menstruation. Journal of Community Medicine and Health Solutions. https://doi.org/10.29328/journal.jcmhs.1001049
Rynkiewicz, A. (2024). Treatment of menopausal vasomotor symptoms and sensory issues in a 53‑year‑old autistic woman: A case report. Bournemouth University ePrint. https://eprints.bournemouth.ac.uk/41029/
Toffol, E., Heikinheimo, O., & Partonen, T. (2015). Hormone therapy and mood in perimenopausal and postmenopausal women: A narrative review. https://www.julkari.fi/handle/10024/126091
Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M. S., Saxena, S., et al. (2022). Global prevalence of autism: A systematic review update. Autism Research, 15(5), 778–790.
